| Global estimates of prevalent and incident herpes simplex virus type 2 infections in 2012 KJ Looker, AS Magaret, KME Turner, P Vickerman, SL Gottlieb, ... PloS one 10 (1), e114989, 2015 | 1114 | 2015 |
| Herpes simplex virus: global infection prevalence and incidence estimates, 2016 C James, M Harfouche, NJ Welton, KME Turner, LJ Abu-Raddad, ... Bulletin of the World Health Organization 98 (5), 315, 2020 | 468 | 2020 |
| The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence KME Turner, S Hutchinson, P Vickerman, V Hope, N Craine, N Palmateer, ... Addiction 106 (11), 1978-1988, 2011 | 416 | 2011 |
| The re-emergence of syphilis in the United Kingdom: the new epidemic phases I Simms, KA Fenton, M Ashton, KME Turner, EE Crawley-Boevey, ... Sexually transmitted diseases 32 (4), 220-226, 2005 | 268 | 2005 |
| Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis KJ Looker, JAR Elmes, SL Gottlieb, JT Schiffer, P Vickerman, KME Turner, ... The Lancet infectious diseases 17 (12), 1303-1316, 2017 | 267 | 2017 |
| Impact of opioid substitution therapy on antiretroviral therapy outcomes: a systematic review and meta-analysis AJ Low, G Mburu, NJ Welton, MT May, CF Davies, C French, KM Turner, ... Clinical Infectious Diseases 63 (8), 1094-1104, 2016 | 240 | 2016 |
| First estimates of the global and regional incidence of neonatal herpes infection KJ Looker, AS Magaret, MT May, KME Turner, P Vickerman, LM Newman, ... The Lancet Global Health 5 (3), e300-e309, 2017 | 224 | 2017 |
| Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings P Vickerman, N Martin, K Turner, M Hickman Addiction 107 (11), 1984-1995, 2012 | 191 | 2012 |
| Risk of Pelvic Inflammatory Disease Following Chlamydia trachomatis Infection: Analysis of Prospective Studies With a Multistate Model MJ Price, AE Ades, D De Angelis, NJ Welton, J Macleod, K Soldan, ... American journal of epidemiology 178 (3), 484-492, 2013 | 185 | 2013 |
| Advances in human palaeopathology R Pinhasi, S Mays John Wiley & Sons, 2008 | 180 | 2008 |
| The natural history of Chlamydia trachomatis infection in women: a multi-parameter evidence synthesis MJ Price, AE Ades, K Soldan, NJ Welton, J Macleod, I Simms, ... Health technology assessment 20 (22), 1-282, 2016 | 167 | 2016 |
| Assessing the reliability of eBURST using simulated populations with known ancestry KME Turner, WP Hanage, C Fraser, TR Connor, BG Spratt BMC microbiology 7, 1-14, 2007 | 163 | 2007 |
| The secret life of the multilocus sequence type KME Turner, EJ Feil International journal of antimicrobial agents 29 (2), 129-135, 2007 | 155 | 2007 |
| Risk of reproductive complications following chlamydia testing: a population-based retrospective cohort study in Denmark B Davies, KME Turner, M Frĝlund, H Ward, MT May, S Rasmussen, ... The Lancet Infectious Diseases 16 (9), 1057-1064, 2016 | 152 | 2016 |
| Effectiveness and cost-effectiveness of traditional and new partner notification technologies for curable sexually transmitted infections: observational study, systematic … CL Althaus, KME Turner, CH Mercer, P Auguste, TE Roberts, G Bell, ... Health technology assessment (Winchester, England) 18 (2), 1-viii, 2014 | 129 | 2014 |
| The cost effectiveness of opportunistic chlamydia screening in England EJ Adams, KME Turner, WJ Edmunds Sexually transmitted infections 83 (4), 267-275, 2007 | 117 | 2007 |
| Global and regional estimates of the contribution of herpes simplex virus type 2 infection to HIV incidence: a population attributable fraction analysis using published … KJ Looker, NJ Welton, KM Sabin, S Dalal, P Vickerman, KME Turner, ... The Lancet Infectious Diseases 20 (2), 240-249, 2020 | 115 | 2020 |
| Modelling the effectiveness of chlamydia screening in England KME Turner, EJ Adams, DS LaMontagne, L Emmett, K Baster, ... Sexually transmitted infections 82 (6), 496-502, 2006 | 108 | 2006 |
| Modelling bacterial speciation WP Hanage, BG Spratt, KME Turner, C Fraser Philosophical Transactions of the Royal Society B: Biological Sciences 361 …, 2006 | 108 | 2006 |
| Developing a realistic sexual network model of chlamydia transmission in Britain KME Turner, EJ Adams, N Gay, AC Ghani, C Mercer, WJ Edmunds Theoretical biology and medical modelling 3, 1-11, 2006 | 99 | 2006 |
Nicky J WeltonUniversity of BristolVerified email at bristol.ac.uk
